Skip to main content

Bench-to-Bedside Program

2004 Bench-to-Bedside Funded Projects

Project Institute or institution/Investigators
Neural substrates underlying motor control of a newly implanted hand transplant NIAMS: Cendales; L
NINDS: Cohen, Leonardo
Development of Non-invasive treatment for uterine leiomyoma (fibroids) NIEHS: Davis, B.
NCI: Partners
: Stratton, Pam CC: Partners
Infrared and Near Infrared Image Guided Minimally Invasive Assessment of Renal Perfusion during Donor Nephrectomies and Partial Nephrectomies NIDDK: Elster, E.; Kirk, Allan
NCI: Partners ORS: Partners
Novel Approach for treatment of squamous cell malignancies with 17-AAG and bortezomib NCI: Gius, D.; Neckers, Len
: Van Waes, Carter
Therapeutic application of intravascular nitrite for sickle cell disease CC: Gladwin, M
: Cannon, Richard
Intermediate phenotype and genetic mechanisms for psychosis and cognitive disturbance in 22q11.2-hemideletion syndrome

NCI: Meyer-Lindenberg, A. 
NIAAA: Goldman, David NIMH: Partners

Molecular profiling of response to proteasome inhibition by bortezomib (PS341) in a clinical trial of mantle cell lymphoma NHLBI: Weistner, Adrian
: Wilson, Wyndham
A Phase I/II pilot study to evaluate the treatment of intraocular lymphoma with BL22 immunotoxin NEI: Nussenblatt, Robert
: Pastan, Ira
Immunotherapy for Myelodysplastic Syndrome NHLBI: Barrett, John
: Douek, Daniel NCI: Rosenberg, Steve
A Phase I Treatment Trial of the Circadian Sleep Disturbance in Smith-Magenis Syndrome (SMS) NHGRI: Smith, Ann
CC: Grimes, George
Pre-clinical non-human primate studies of an invo selectable vector intended for use in a planned clinical trial of gene therapy for chronic granulomatous disease NIAID: Malech, Harry
: Dunbar, Cynthia
solation and Characterization of Circulating Endothelial Cells in Primary Pulmonary Hypertension: Implications for Early Diagnosis and Novel Therapeutic Targets CC: Solomon, Michael; Danner, Robert
: Partners
Evaluation of the anti-IL-2/IL-15Rb monoclonal antibody Hu MiK-b-1 in a therapeutic trial in patients with HAM/TSP and a test of hypotheses concerning the role of IL-15 in the maintenance of CD8+ memory T-cells and in the pathogenesis of HAM/TSP NINDS: Jacobson, Steven
NCI: Waldmann, Thomas
: Fleisher, Thomas
Childhood Cancer and Plexiform Neurofibroma Tissue Microarray for Molecular Target Screening and Clinical Drug Development NCI: Fox, E.
: Baird, K.
Molecular profiling and drug discovery for patients with PTEN Hamartomatous Tumor Syndromes (PHTS) NCI: Dennis, P.
NHGRI: Elkahoun, A.
Assessing the safety and immunogenicity of a therapeutic vaccination strategy using a DNA plasmid vaccine prime and a recombinant adenovector boost in HIV infected adults NIAID: Graham, Barney
NCI: Partners
Targeting vascular endothelial growth factor-A (VEGF-A) and receptor-2 (VEGFR-2) for the treatment of Primary Effusion Lymphoma NCI: Tosato, Giovanna; Yarchoan, Robert
NIAID: Partners
Pediatric NeuroAIDS in the HAART Era: Identification of Disease Markers and Therapeutic Targets NCI: Hazra, R.
: Major, Eugene; Schwartz, L.
Treatment of Primary-Effusion Lymphoma with Combination Virolytic and Cytotoxic Chemotherapy NCI: Yarchoan, Robert; Little, Richard
: Cohen, Jeffrey

Previous Awards Funded

2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999

NOTE: PDF documents require the free Adobe Reader.

This page last updated on 03/27/2018

You are now leaving the NIH Clinical Center website.

This external link is provided for your convenience to offer additional information. The NIH Clinical Center is not responsible for the availability, content or accuracy of this external site.

The NIH Clinical Center does not endorse, authorize or guarantee the sponsors, information, products or services described or offered at this external site. You will be subject to the destination site’s privacy policy if you follow this link.

More information about the NIH Clinical Center Privacy and Disclaimer policy is available at